GSK
GSK·NYSE
--
--(--)
--
--(--)
3.88 / 10
Netural
The security demonstrates subpar fundamental health (3.9/10). Positive indicators include a favorable cost of sales ratio and strong interest coverage, while risks arise from elevated days sales outstanding and tax burden. Overall, the fundamental stance is guarded.
Analysis Checks(6/10)
Revenue-MV
Value0.55
Score2/3
Weight19.56%
1M Return9.81%
Value0.55
Score2/3
Weight19.56%
1M Return9.81%
Profit-MV
Value1.36
Score3/3
Weight23.94%
1M Return12.21%
Value1.36
Score3/3
Weight23.94%
1M Return12.21%
Income tax / Total profit (%)
Value13.78
Score0/3
Weight-2.10%
1M Return-1.45%
Value13.78
Score0/3
Weight-2.10%
1M Return-1.45%
Operating revenue (YoY growth rate %)
Value3.40
Score1/3
Weight-0.42%
1M Return-0.28%
Value3.40
Score1/3
Weight-0.42%
1M Return-0.28%
Asset-MV
Value-0.50
Score1/3
Weight18.63%
1M Return8.51%
Value-0.50
Score1/3
Weight18.63%
1M Return8.51%
Days sales outstanding
Value82.93
Score1/3
Weight-1.46%
1M Return-0.98%
Value82.93
Score1/3
Weight-1.46%
1M Return-0.98%
PB-ROE
Value0.41
Score2/3
Weight24.30%
1M Return11.46%
Value0.41
Score2/3
Weight24.30%
1M Return11.46%
Interest coverage ratio (EBIT / Interest expense) (%)
Value17.84
Score2/3
Weight-1.00%
1M Return-0.66%
Value17.84
Score2/3
Weight-1.00%
1M Return-0.66%
Cost of sales ratio (%)
Value26.45
Score3/3
Weight1.22%
1M Return0.72%
Value26.45
Score3/3
Weight1.22%
1M Return0.72%
Cash-MV
Value0.73
Score2/3
Weight17.33%
1M Return7.70%
Value0.73
Score2/3
Weight17.33%
1M Return7.70%
Revenue-MV
Value0.55
Score2/3
Weight19.56%
1M Return9.81%
Value0.55
Score2/3
Weight19.56%
1M Return9.81%
Days sales outstanding
Value82.93
Score1/3
Weight-1.46%
1M Return-0.98%
Value82.93
Score1/3
Weight-1.46%
1M Return-0.98%
Profit-MV
Value1.36
Score3/3
Weight23.94%
1M Return12.21%
Value1.36
Score3/3
Weight23.94%
1M Return12.21%
PB-ROE
Value0.41
Score2/3
Weight24.30%
1M Return11.46%
Value0.41
Score2/3
Weight24.30%
1M Return11.46%
Income tax / Total profit (%)
Value13.78
Score0/3
Weight-2.10%
1M Return-1.45%
Value13.78
Score0/3
Weight-2.10%
1M Return-1.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value17.84
Score2/3
Weight-1.00%
1M Return-0.66%
Value17.84
Score2/3
Weight-1.00%
1M Return-0.66%
Operating revenue (YoY growth rate %)
Value3.40
Score1/3
Weight-0.42%
1M Return-0.28%
Value3.40
Score1/3
Weight-0.42%
1M Return-0.28%
Cost of sales ratio (%)
Value26.45
Score3/3
Weight1.22%
1M Return0.72%
Value26.45
Score3/3
Weight1.22%
1M Return0.72%
Asset-MV
Value-0.50
Score1/3
Weight18.63%
1M Return8.51%
Value-0.50
Score1/3
Weight18.63%
1M Return8.51%
Cash-MV
Value0.73
Score2/3
Weight17.33%
1M Return7.70%
Value0.73
Score2/3
Weight17.33%
1M Return7.70%
Is GSK undervalued or overvalued?
- GSK scores 3.88/10 on fundamentals and holds a Fair valuation at present. Backed by its 39.36% ROE, 19.25% net margin, 15.97 P/E ratio, 5.72 P/B ratio, and 139.77% earnings growth, these metrics solidify its Netural investment rating.
